Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients' risk of developing heart problems. A recent ...
Jul 25, 2022
0
5
Exposure to traffic-related air pollution may be associated with an increased risk for childhood leukemia, according to a study published in the August issue of Environment International.
Jul 21, 2022
0
19
For patients with stage III or IV Hodgkin lymphoma, brentuximab vedotin is associated with a survival advantage, according to a study published online July 13 in the New England Journal of Medicine.
Jul 14, 2022
0
1
Individuals without private health insurance coverage are more likely to be diagnosed with late-stage cancer and have worse survival, according to a study published online July 13 in CA: A Cancer Journal for Clinicians.
Jul 13, 2022
0
6
New light is being shed on the mechanisms underlying the malignant transformation of lymphomas, paving the way for a promising therapeutic target, thanks to research conducted by a team led by Université de Montréal professor ...
Jul 11, 2022
0
25
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators ...
Jun 28, 2022
0
5
Among pregnancies complicated by cancer, the risks for severe maternal morbidity and mortality are increased, according to a research letter published online June 16 in JAMA Oncology.
Jun 22, 2022
0
3
Arsenic seems to have a dual effect on carcinogenesis, according to a study recently published in Frontiers in Public Health.
Jun 20, 2022
0
2
A federal appeals court has ruled that the EPA must take another look at whether the key ingredient in the weed killer Roundup poses a cancer risk, although the product will remain on the market for now.
Jun 20, 2022
0
3
Combination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for previously untreated mantle cell lymphoma (MCL) ...
Jun 3, 2022
0
35
